Skip to content
Catalyst

PapersPMID:35699663

Association between plasma Vitamin B5 levels and all-cause mortality: A nested case-control study.

Journal of clinical hypertension (Greenwich, Conn.)2022The record ↗

  1. Finding, very limited evidenceraisesAll-cause mortality

What moved

1 findingHow to read these marks →
  • Increases all-cause mortality

    very limited

    “All‐cause mortality risk increased with the increase in plasma vitamin B5 concentrations.”
    Study
    case-control
    Population
    Chinese adults aged 45-75 years with hypertension, nested case-control study within the China Stroke Primary Prevention Trial (505 deaths and 505 matched controls; all participants on enalapril with or without folic acid); baseline plasma vitamin B5 measured, not administered

Study record

Design
case-control study
Species
human
Population
Chinese adults with hypertension in the China Stroke Primary Prevention Trial (CSPPT): 505 all-cause deaths and 505 matched controls
Participants
1,010
Comparator
observational
Duration
1,644 days
Endpoints measured
35